Increased risk of malignancies in patients with bullous pemphigoid (BP);Erhohtes risiko von malignomerkrankungen bei patienten mit bullosem pemphigoid

Aktuelle Dermatologie

Volumn 26, Issue 3, 2000, Pages 53-59

  Rzany, B ^a   Danckwardt, C ^a   Jung, M ^a   Schuhmann, M ^a   Messer, G ^b   Bayerl, Christiane ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GERMANY; HOSPITAL PATIENT; HUMAN; MALE; PEMPHIGOID;

EID: 0034027219     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetbianc JM, Prost C Builous Disease French Study Group. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995; 131: 48-52
2. Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Bröcker EB. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995; 131: 957-953
3. Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients. A popula-tion-based study on incidence. J Am Acad Dermatol 1999; 41: 266-268
4. Messer G. Dermoepidermale Grenzzone. In: Plewig G, Wolff H (Hrsg). Fortschritte der praktischen Dermatologie und Venerologie 1998. Berlin, Heidelberg: Springer, 1999: 99-109
5. Zillikens D. Acquired skin diseases of hemidesmosomes. J Dermatol Sci 1999; 20: 134-154
6. Ghohestani RF, Nicolas JF, Rouselle P, Claudy AL. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1997; 133: 1102-1107
7. Abadir R. Pemphigoid, bronchial neoplasm and radiotherapy. Proc R Soc Med 1967; 60: 33-34
8. Amer MH, Akhtar M, Mackey DM, Butler PG. Bullous pemphigoid after chemotherapy for choriocarcinoma. Int J Dermatol 1982; 21: 32-35
9. Binet O, Brunetiere RA, Rabay G, Carelly EB, Galian A, Villet R. Immunologic studies of bullous pemphigoid associated with adenocarcinoma of the colon. N Engl J Med 1983; 308: 460-461
10. Blum A, Wehner-Caroli J, Schwerwitz C, Rassner G. Bullöses Pemphigoid als paraneoplastisches Syndrom. Hautarzt 1997; 48: 834-837
11. Ernst TM, Marsch W. Induktion eines lokalisierten Pemphigoids durch energiereiche Strahlen. Dermatologica 1982; 164: 73-81
12. Gaspari AA, Marchese S, Powell D, Rady PL, Tyring S. Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. J Am Acad Dermatol 1997; 37: 843-847
13. Mondiano P, Reichert S, Barbaud A, Bernard P, Weber M, Schmutz JL Bullous pemphigoid in association with cutaneous lesions specific to a myelodysplastic syndrome. Br J Dermatol 1997; 136: 402-405
14. Muramatsu T, Iida T, Tada H, Hatoko M, Kobayashi N, Ko T, Shirai T. Bullous pemphigoid associated with internal malignancies: identification of 180 kDa antigen by Western immunoblotting. Br J Dermatol 1996; 135: 782-784
15. Ohata C, Shirabe H, Takagi K, Kawatsu T, Hashimoto T. Localized bullous pemphigoid after radiation therapy. Acta Derm Venereol (Stockh) 1997; 77: 157-175
16. Parsons RL, Savin JA. Pemphigoid and malignancy. Br J Cancer 1968; 22: 569-572
17. Tanaka T, Ogino A, Ogura K, Nakagawa K, A case of bullous pemphigoid and transitional cell carcinoma of the bladder. Arch Dermatol 1983; 119: 704-705
18. Van Poppel H, Aswarie H, Baert L. Bullous pemphigoid associated with renal carcinoma. Br J Urol 1988; 61: 361-
19. Ogawa H, Sakuma M, Morioka S, Kitamura K, Sasai Y, Imanura S, Inaba Y. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Science 1995; 9: 136-141
20. Ahmed AR, Chu TM, Provost T. Bullous pemphigoid. Clinical and serologic evaluation for associated neoplasms. Arch Dermatol 1977; 113: 969-
21. Lindelöf B, Islam N, Eklund G, Arfos L. Pemphigoid and cancer. Arch Dermatol 1990; 126: 66-68
22. Venning VA, Wojnarowska F. The association of bullous pemphigoid and malignant disease: a case-control study. Br J Dermatol 1990; 123: 439-445
23. Stone SP, Schroeter AI. Bullous Pemphigoid and Malignant Neo-plasmas. Arch Dermatol 1975; 111: 991-994
24. Schlesselman JJ. Case-control studies. Design, Conduct, Analysis. New York: Oxford University Press. 1982
25. Brown GW. Berkson Fallacy and Studies on reserpine and breast cancer. Am J Dis Chil 1976; 130: 1164-1165
26. Bergmann MM, Calle E, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW. The validity of self reported cancers in a prospective cohort study in comparison to data from state cancer registries. Am J Epidemiol 1998; 147: 556-562
27. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R for the Study Group of the International Case-Control Study on Severe Cutaneous Adverse Reactions. Increased Risk for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the First Weeks of Antiepileptic Therapy. Results of a case-control study. Lancet 1999; 335: 2190-2193
28. Kjaer SK, Engholm G, Dahl C, Bock JE. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: role of smoking habits. Eur J Cancer Prev 1996; 5: 359-365